Immunoglobulins Market is anticipated to reach US$ 20,757.1

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
19
Immunoglobulins Market is anticipated to reach US$ 20,757.1 Mn by 2026 - TMR

Albany, New York, Jan. 04, 2019 (GLOBE NEWSWIRE) -- Transparency Market Research (TMR) has published a new report titled, “ Immunoglobulins Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global immunoglobulins market was valued at US$ 10,980 Mn in 2017. The market is anticipated to reach US$ 20,757.1 Mn by 2026, expanding at a CAGR of 7.2% during the forecast period. Rise in incidences of autoimmune, neurological, hematological disorders, and increasing geriatric population are expected to augment the global market from 2018 to 2026. The global immunoglobulins market is projected to expand owing to increasing healthcare investments, acceptance and rising demand for subcutaneous infusion IG, and rise in usage of off-label indications in various economies.

Request to View Sample of Report - https://www.transparencymarketresearch.com/sa...p_id=52353

Rise in prevalence of autoimmune, neurological and hematological disorders is propelling the global market

The global immunoglobulin market is expanding at a high growth rate driven by an increase in prevalence of autoimmune diseases such as primary humoral immunodeficiency (PIDD), multiple sclerosis, immune thrombocytopenia purpura (ITP), autoimmune hemolytic anemia, Kawasaki syndrome, systemic lupus erythematosus, and rheumatoid arthritis. According to the Immune Deficiency Foundation (IDF), approximately 83 people per 100,000 in the U.S. suffer from primary immunodeficiency, and there are more than 5 million undiagnosed cases in the U.S. alone. About 6 million people are suffering from Primary immunodeficiency (PID). As of June 2018, the occurrence of myasthenia gravis in the U.S. was assessed at 14 to 20 per 100,000, or around 36,000 to 60,000 cases. According to the research published by NORD (National organization for rare disorders), in the U.S., the prevalence of ITP in adults and children’s has also increased.

Request PDF Brochure of Report - https://www.transparencymarketresearch.com/sa...p_id=52353

Increase in global geriatric population is driving the need for effective treatment, globally

Prevalence of several diseases, such as cancer, diabetes, and neurological disorders, is rising due to a rapidly increasing geriatric population, resulting in surge in incidences of secondary Immunodeficiencies (SID), more common than PID. According to the WHO, the global geriatric population is expected to increase from 524 million in 2010 to 1.5 billion by 2050.

Rising geriatric population demands better treatment options for newer diseases, which in turn, would provide opportunities for companies operating in the global immunoglobulin market.

Request For Discount On This Report - https://www.transparencymarketresearch.com/sa...p_id=52353

Acceptance and rising demand for subcutaneous infusion IG and rising immunoglobulin usage in off-label indication is an advantage to the market

Awareness related to subcutaneous infusion has increased due to its easy administration as compared to intravenous injection. Acceptance of subcutaneous immunoglobulin (SCIG) infusion is rising, as it offers advantage for patients with lowers venous access and improves the quality of life of patients. In few patients with IG replacements, SCIG is more advantageous. Moreover, steady increase in the usage of immunoglobulins for the treatment of off-label indications is expected to boost the global market. Common off-label indications treated with intravenous & subcutaneous immunoglobulins are Guillain-Barre syndrome, multifocal motor neuropathy, dermatomyositis, polymyositis, stiff person syndrome, and relapsing-remitting multiple sclerosis.

Request For Custom Research - https://www.transparencymarketresearch.com/sa...p_id=52353

North America dominates the global market owing to rise in demand for intravenous immunoglobulin infusion (IVIG) and adoption of subcutaneous immunoglobulin infusions (SCIG)

North America dominates the global immunoglobulin market presence of major players account for a prominent share in this region and rising prevalence of disorders with new diseases in line. IVIG is treated as the strong way to overcome autoimmune and neurological diseases, as it is a faster and effective therapy with better understanding of the antibody deficiency.

SCIG is gaining trust and popularity among children and the geriatric population, as it is easy to administer and preference of homecare settings. Therefore, easy adoption of SCIG is fuelling the market in the region.

Browse Press Release - https://www.transparencymarketresearch.com/pr...market.htm

Worldwide increase in plasma production and benefits of immunoglobulins in newer indications offer significant opportunities to new entrants

Rise in yielding plasma fulfills the global demand for plasma products, which is expected to provide lucrative opportunities to new players in the immunoglobulins market. Intravenous and subcutaneous immunoglobulins are employed in patients with primary and secondary immunodeficiency disorders, which helps combat infections. Various key players have been making significant investments in R&D programs for developing IVIG, SCIG, and IMIG applications in newer indications. Promising results in various novel clinical applications are expected to provide growth opportunities to the immunoglobulins market during the forecast period.

Investments by key players is driving the immunoglobulins market

Key players dominating the global immunoglobulins markets are Shire, CSL Behring, Kedrion Biopharma Inc, Grifols, S.A., Octapharma, China Biologic Products Holdings, Inc, Biotest AG, Sanquin, and LFB SA. Key players are focusing on geographic expansion through acquisitions and collaborations to enhance their footprint in the global immunoglobulins market.

More Trending Reports by Transparency Market Research:

About TMR

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact Mr. Rohit Bhisey Transparency Market Research State Tower 90 State Street, Suite 700, Albany, NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email : sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com

Research Blog: http://theglobalhealthnews.com/

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 112

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 94

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Fraud0-FouAnalytics Takes Aim at Legacy Ad Verification

Updated Category News Views 160

Digital ad measurement has spent years grading its own homework, and that little arrangement may finally be getting some daylight. fraud0 and FouAnalytics say their expanded partnership will give advertisers impression-level visibility into where ads actually rendered, whether apparent humans engaged with them, and where wasted Google Ads spend might be recoverable. The...

Continue Reading
Maryland Handgun Ban Suit Puts Ruger in Legal Crossfire

Updated Category News Views 135

A January Deadline With Real Commercial Teeth Maryland has turned a trigger-design dispute into a fresh legal and retail headache, and the clock is not polite about it. The National Shooting Sports Foundation filed suit against the state over S.B. 334, which is scheduled to take effect Jan. 1, 2027. The law bars sales of certain pistols with cruciform trigger bars,...

Continue Reading
QuidelOrtho Faces Fresh Scrutiny Over Savanna Claims

Updated Category News Views 157

A diagnostic launch can turn into a corporate migraine with frightening speed, and QuidelOrtho is staring at exactly that sort of mess. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether QuidelOrtho officers or directors breached fiduciary duties or otherwise violated state or federal law. This is not a finding of wrongdoing. It is an...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 142

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
Midterm Voters Put Cost Relief Ahead of Washington Wars

Updated Category News Views 118

Gas pumps and medical bills have a way of humiliating every grand political slogan ever printed. Seven Letter Insight's latest post-election survey says confirmed 2026 midterm voters want the 120th Congress to deal with costs first, particularly gas prices, health care, restoring health care tax credits and energy bills. That is not a glamorous mandate. It is, however,...

Continue Reading
Epic Blue Puts $50,000 of Marketing Work to Use Locally

Updated Category News Views 111

A $50,000 pile of donated know-how can look soft on a spreadsheet, until you remember how often a small nonprofit or early-stage outfit gets ignored because it cannot afford someone to sharpen its message. Epic Blue Marketing, a women-owned firm based in Jackson, Michigan, says it provided that amount in donated and reduced-rate marketing, communications and public...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 97

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
CCAPP Holiday Training Targets Seasonal Recovery Strain

Updated Category News Views 94

December cheer has a nasty habit of hiding the people barely holding themselves together. CCAPP’s upcoming virtual workshop, Hope for the Holidays: Understanding Depression, Stress & Resilience During the Holiday Season, takes that uncomfortable reality seriously rather than treating it like a seasonal footnote. For behavioral health workers supporting people in...

Continue Reading

Top 5 Most Recently Viewed Articles

Health-Ade Partners with Wheel of Fortune and Ryan Seacrest

Updated Category News Views 212

Health-Ade Shines at Wheel of Fortune Premiere Health-Ade is thrilled to announce its prominent involvement in the premiere week of the classic game show, Wheel of Fortune, as it embarks on an exciting new journey with Ryan Seacrest as the show's host. This is an exhilarating moment not only for Wheel of Fortune but also for Health-Ade Kombucha, which is celebrated for...

Continue Reading
Investment Fund Trends and Insights for October 2024

Updated Category News Views 101

Mutual Fund and ETF Asset Management In the scope of mutual funds and exchange-traded funds (ETFs), the latest insights reveal a steady growth in assets and sales throughout the investment landscape. As investors look for diverse options, investment funds have shown resilience and dynamic adaptability, showcasing robust growth metrics in their respective categories....

Continue Reading
S&P and Pantera Take Digital Asset Indexing to New Heights

Updated Category News Views 18

Digital Assets: A New Benchmark in Town Date it, folks: July 21, 2026. S&P Dow Jones Indices and Pantera Capital are rolling out a fresh digital asset index. They're slapping the 'S&P Pantera' name on something focused less on the casino vibe you get from memes and Bitcoin mania, and more on actual economic value and real-world use. Flipping the script on the way most of...

Continue Reading
Gundry MD Wins Big with Innovative Softgel Formula

Updated Category News Views 57

Breaking New Ground in Weight Management Forget the caffeine-laden pills and appetite-killer potions—here comes something that simply whispers to your gut and says, "Manage your weight naturally." That's what Gundry MD's Daily Weight Advantage™ has cooked up, bagging the prestigious NutraIngredients-USA's Weight Management Product of 2026 award. Finally, a product...

Continue Reading
Ciena's Options Market Insights: Bullish Trends and Growth Prospects

Updated Category News Views 202

Understanding Ciena's Recent Options Activity Investors with significant resources have shown a clear bullish sentiment towards Ciena (NYSE: CIEN), indicating crucial trends that market observers should consider. By monitoring options records, it’s clear that substantial movements are occurring within the CIEN stock, hinting that noteworthy developments might be on the...

Continue Reading